Ignite Creation Date:
2025-12-25 @ 4:11 AM
Ignite Modification Date:
2026-02-24 @ 8:27 AM
Study NCT ID:
NCT00493220
Status:
COMPLETED
Last Update Posted:
2011-12-02
First Post:
2007-06-26
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration
Sponsor:
Baxter Healthcare Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Healthy | View |